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Infantile neuronal ceroid lipofuscinosis (INCL) is a recessively inherited progressive encephalo­
pathy. The aim of the study was to demonstrate the course of INCL with brain MRl, and to correlate 
MRI with histopathological findings. The authors also wanted to ascertain by quantitative analysis 
at what age the first pathological changes could be measured— since storage material is known to 
be present even in the fetus'— the location of these changes, and their rate of progression. 21 
patients aged three months to 11 years, 46 neurologically normal controls of the same age, and eight 
formalin-fixed brains of INCL patients (children's age range at death seven to 13 years) were exam­
ined by MRI at LOT. In addition to visual evaluation, the signal intensity of the premortem MRls was 
measured in numerous locations. The prenatal and postnatal development of the central nervous 
structures began normally, as demonstrated by MRI and in conformity with the neuropathological 
findings2, at least until the age of three months. However, pathological findings were detected both 
visually and quantitatively even before clinical signs. The radiological picture of the brain varied 
with the duration of the disease. Generalized cerebral atrophy, more obvious than cerebellar, strong 
thalamic hypo-intensity in the white matter and basal ganglia, and thin periventricular high-signal 
rims from 13 months onward on Ta-weighted images with the typical clinical picture were pathog­
nomonic findings in the early stage of INCL. Wallerian degeneration2,1 and increased interstitial fluid 
in the white matter may account for the increased white matter intensity.
The authors suggest that the decreased T2 signal intensity in the thalami is due to the change in 
the components of the storage material. According to the quantitative analysis, they also assume 
that in the early stages of INCL more storage material accumulates in the thalami than in the basal 
ganglia. In the final stage, after the age of four years, cerebral atrophy is extreme and the grey 
matter is hypo-intense compared with the white matter, the reverse o f normal. The signal intensity 
of the white matter is higher than that of the cerebrospinal fluid, m r i  findings o f the final stage of 
the disease and of the postmortem examinations did not differ significantly. The drastically altered 
relative intensities of the grey and white matter structures on MRI reflected incomplete replacement 
of the neurons with abnormal hypertrophic astrocytes and/or macrophages filled with storage 
material. The abnormalities progress on m r i  during the first four years o f life, then stabilize, in 
conformity with the clinical and histopathological picture of INCL.
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Cerebrotendinous xanthomatosis (CTX) is a rare, autosomal recessive lipid-storage disease which 
is caused by an enzymatic defect (hepatic 27-hydroxylase) in the synthesis of bile acids out o f  
cholesterol, leading to the accumulation of cholestanol and cholesterol in the tissues. Biochemical 
diagnosis is made by the determination of excessive urinary excretion of bile alcohols and by the 
ratio o f serum cholestanol and cholesterol levels. Clinical characteristics of the disease are prema-
ture cataract, formation of tendinous xanthomas, premature coronary heart disease and 
neurological abnormalities, i.e. dementia, pyramidal and cerebellar signs, and peripheral neuro­
pathy. Although in many patients the onset of symptoms is in childhood, CTX is seldom diagnosed
before 20 years of age.
The authors describe five children varying in age from seven to 29 years at diagnosis. Their 
clinical course, laboratory findings and development after starting therapy are presented and the 
results are discussed. In all five children (seven to 20 years) the diagnosis CTX was biochemically 
proven. All patients had abnormal bile alcohols in their urine. Serum cholestanol content 
exceeded the 40p m ol/L  (reference value: 3.3 to 12.5 fjmol/L), and the cholestanol/cholesterol 
ratio varied from 1.21 to 2 .19  (normal value: 0.08  to 0 .2 1 ). Clinical characteristics of the patients 
were intractable diarrhoea, bilateral cataract, mild to moderate mental retardation and delay o f  
motor development in three (aged seven, 12 and 13 years), and cerebellar signs in two patients 
(aged 17 and 20 years). After the start of therapy with chenodeoxycholic acid, the diarrhoea
disappeared with an improvement of subjective well-being and mental functioning. 
Determination of the enzymatic activity of the mitochondrial 27-hydroxylase and the defect at 
the d n a  level is in progress, ctx  is seldom diagnosed in childhood. The onset of typical neuro­
logical symptoms and signs are nearly always in the second decade. Intractable non-infectious 
diarrhoea has not been described earlier regarding any clinical spectrum o f CTX. This diagnosis 
should be considered in any combination of cataract, diarrhoea and neurological symptoms and
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ACTH is the most recommended drug for the treatment of spasms in West syndrome, but it is 
frequently associated with serious side-effects. Research for alternative therapies with greater bene­
fits is the object of many studies. The authors compared vigabatrin (GVG) and ACTH as first-line 
therapy for West syndrome. Patients were randomly assigned to GVG 100 to 150mg/kg/day or to 
ACTH depot 0.1 mL/day. After 20 days, if there was no significant clinical/EEG improvement, the other 
drug was given to the patient. 35 newly diagnosed and untreated patients with West syndrome were 
included in the trial: 20 males and 15 females, aged four to nine months. 18 patients, four cryptoge- 
netic and 14 symptomatic, received ACTH as their first drug. Disappearance of spasms was observed 
in nine patients (9/18; 50 per cent) treated with GVG (three cryptogenic and six symptomatic) and in 
10 patients (13/17; 77 per cent) treated with ACTH (six cryptogenic and seven symptomatic). GVG 
response occurred within eight days. Treatment intolerance was observed in two cases, one treated 
with gvg  and one treated with ACTH. Disappearance of interictal EEG abnormalities was faster in 
patients treated with ACTH than in those treated with GVG. Nine patients not responding to GVG had 
a good response when treated with ACTH. Three o f four patients not responding to ACTH, had a good 
response when treated with GVG. After three months, relapses were more numerous in patients 
treated with ACTH. These data demonstrate that GVG is effective in 50 per cent of cases with West 
syndrome, both cryptogenic and symptomatic; its safety profile is good. This drug can be suggested 
as a first-choice treatment for infantile spasms, before starting ACTH treatment.
NEW AND PROMISING DRUGS FOR EPILEPSY
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In approximately 20 per cent of patients with epilepsy, seizures are resistant to long-established 
drugs. Development of new therapy remains important. Seizures occur under three main condi­
tions: impaired GABA-mediated inhibition, enhanced glutamate/aspartate transmission, 
endogenous bursting of subsets of pyramidal neurons. Brain g a b a  is increased by vigabatrin, 
tiagabine and stiripentol. Of these, only vigabatrin, an effective drug for partial seizures and infan­
tile spasms, is licensed. Lamotrigine impairs glutamate/aspartate transmission, has a wide profile 
and is useful for typical and atypical absences, drop attacks and partial seizures. Remacemide, a
